The novel approach of this peptide represents a major development in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment